CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 8-K Event Other events
- 4 Open-market sale Chief Financial Officer sold 3,840 shares at $12.13 ($46,579)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market buy Chief Financial Officer bought 3,389 shares at an average $7.96 ($26,982)
- 4 Open-market buy Director bought 2,561 shares at an average $8.23 ($21,086)
- 4 Open-market buy Chief Financial Officer bought 1,200 shares at $9.09 ($10,908)
- 4 Open-market buy Director bought 10,000 shares at $9.31 ($93,100)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 14 of 22 · 424 filings